ArticleHaematologica2022

Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect.

Roberta Pece et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.